New developments for anti-HIV treatment (2015)
- Authors:
- Autor USP: CASSEB, JORGE SIMÃO DO ROSÁRIO - IMT
- Unidade: IMT
- Subjects: HIV; TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in clinical drug research : HIV
- Volume/Número/Paginação/Ano: 289 p.
-
ABNT
ARRUDA, Liã Bárbara e CASSEB, Jorge Simão do Rosário. New developments for anti-HIV treatment. Frontiers in clinical drug research : HIV. Tradução . Sharjah: Bentham, 2015. p. 289 . . Acesso em: 05 mar. 2026. -
APA
Arruda, L. B., & Casseb, J. S. do R. (2015). New developments for anti-HIV treatment. In Frontiers in clinical drug research : HIV (p. 289 ). Sharjah: Bentham. -
NLM
Arruda LB, Casseb JS do R. New developments for anti-HIV treatment. In: Frontiers in clinical drug research : HIV. Sharjah: Bentham; 2015. p. 289 .[citado 2026 mar. 05 ] -
Vancouver
Arruda LB, Casseb JS do R. New developments for anti-HIV treatment. In: Frontiers in clinical drug research : HIV. Sharjah: Bentham; 2015. p. 289 .[citado 2026 mar. 05 ] - Is the rate of CD4 cell decline changing over time in antiretroviral-naïve patients?
- Genetic markers of the host in persons living with HTLV-1, HIV and HCV infections
- Cytokine networks dysregulation during HTLV-1 infection and associated diseases
- Aids: complicações neurológicas
- HTLV-1/2 prevalence in two Amazonian communities
- Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial
- Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients
- Manifestações dermatológicas na síndrome da imunodeficiência adquirida
- In vitro basal T-cell proliferation among asymptomatic Human T cell Leukemia Virus type 1 patients co-infected with hepatitis C and/or Human Immunodeficiency Virus type 1
- Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
